Endoscopic Perfusion Utilizing ICG Fluorescence Technology

NCT02383628 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 197

Last updated 2018-07-05

No results posted yet for this study

Summary

The main objective of the study is to evaluate the efficacy of indocyanine green (ICG) endoscopy to evaluate tissue perfusion during endoscopic neurosurgery. This includes patients with pituitary and intracranial tumors and treatment of vascular abnormalities such as aneurysms and compressive syndromes. ICG will be evaluated to determine the value of the additional visual information supplied during the treatment of these pathologies.

Conditions

  • Quality of Life

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Paul Gardner, MD · University of Pittsburgh Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02383628 on ClinicalTrials.gov